News Room
News Room
News Room
Emalex Biosciences Named “Neuroscience Therapeutics Company Of The Year” by BioTech Breakthrough
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industries CHICAGO, November 19, 2024 – Emalex Biosciences was named “Neuroscience [...]
Article Highlights Positive Study Results Presented at AAN Annual Meeting
By Mary Beth Nierengarten, April 1, 2024 – Ecopipam reduced the number of tics and the level of daily interference they cause in children [...]
Harmony Biosciences Ranked Among Top 25 Fastest-Growing Companies in North America on the 2023 Deloitte Technology Fast 500™
Ranking attributed to 7,204% growth from fiscal year 2019 to 2022 PLYMOUTH MEETING, Pa., Nov. 15, 2023 /PRNewswire/ – Harmony Biosciences Holdings, Inc. ("Harmony" [...]
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
New investor OrbiMed expects platform to reduce development time for novel treatments and therapeutic approaches CHICAGO - BUSINESS WIRE, September 27, 2023 – Evozyne [...]
Harmony Biosciences to Acquire Zynerba Pharmaceuticals, Inc.
Acquisition expands pipeline and diversifies portfolio to drive long-term growth Innovative potential new therapeutic option for rare/orphan neuropsychiatric disorders with high unmet medical needs [...]
Harmony Biosciences Announces Jeffrey M. Dayno, M.D. Appointed President & Chief Executive Officer
– Dr. Dayno joins Harmony Biosciences Board of Directors – PLYMOUTH MEETING, PA, April 24, 2023 – Harmony Biosciences Holdings, Inc. (“Harmony” or the [...]
